375 related articles for article (PubMed ID: 36494147)
1. Vaccine-induced immune thrombotic thrombocytopenia.
Kanack AJ; Padmanabhan A
Best Pract Res Clin Haematol; 2022 Sep; 35(3):101381. PubMed ID: 36494147
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia.
Huynh A; Arnold DM; Ivetic N; Clare R; Hadzi-Tosev M; Liu Y; Smith JW; Bissola AL; Daka M; Kelton JG; Nazy I
J Thromb Haemost; 2023 Oct; 21(10):2833-2843. PubMed ID: 37394121
[TBL] [Abstract][Full Text] [Related]
3. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response.
Franceschi AM; Petrover DR; McMahon TM; Libman RB; Giliberto L; Clouston SAP; Castillo M; Kirsch C
Clin Imaging; 2022 Oct; 90():63-70. PubMed ID: 35926315
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond.
Greinacher A; Warkentin TE
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):1-10. PubMed ID: 38066843
[TBL] [Abstract][Full Text] [Related]
5. Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies.
Kanack AJ; Singh B; George G; Gundabolu K; Koepsell SA; Abou-Ismail MY; Moser KA; Smock KJ; Green D; Major A; Chan CW; Wool GD; Reding M; Ashrani AA; Bayas A; Grill DE; Padmanabhan A
Am J Hematol; 2022 May; 97(5):519-526. PubMed ID: 35132672
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
McGonagle D; De Marco G; Bridgewood C
J Autoimmun; 2021 Jul; 121():102662. PubMed ID: 34051613
[TBL] [Abstract][Full Text] [Related]
8. Potential mechanisms of vaccine-induced thrombosis.
Marietta M; Coluccio V; Luppi M
Eur J Intern Med; 2022 Nov; 105():1-7. PubMed ID: 35953336
[TBL] [Abstract][Full Text] [Related]
9. Understanding vaccine-induced thrombotic thrombocytopenia (VITT).
Dix C; McFadyen J; Huang A; Chunilal S; Chen V; Tran H
Intern Med J; 2022 May; 52(5):717-723. PubMed ID: 35446471
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia.
Warkentin TE; Greinacher A
Thromb Res; 2021 Aug; 204():40-51. PubMed ID: 34144250
[TBL] [Abstract][Full Text] [Related]
11. Serotonin Release Assay: Functional Assay for Heparin- and Vaccine-Induced (Immune) Thrombotic Thrombocytopenia.
Kondo M; Donikian D; Brighton TA
Methods Mol Biol; 2023; 2663():463-477. PubMed ID: 37204730
[TBL] [Abstract][Full Text] [Related]
12. Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story.
Tsilingiris D; Vallianou NG; Karampela I; Dalamaga M
Metabol Open; 2021 Sep; 11():100101. PubMed ID: 34179744
[TBL] [Abstract][Full Text] [Related]
13. Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder.
Venier LM; Clerici B; Bissola AL; Modi D; Jevtic SD; Radford M; Mahamad S; Nazy I; Arnold DM
Int J Hematol; 2023 Mar; 117(3):341-348. PubMed ID: 36574172
[TBL] [Abstract][Full Text] [Related]
14. Uncommon thrombotic complications after SARS-CoV-2 vaccination.
Musil D
Vnitr Lek; 2021; 67(5):297-302. PubMed ID: 35459396
[TBL] [Abstract][Full Text] [Related]
15. Whole Blood Procoagulant Platelet Flow Cytometry Protocol for Heparin-Induced Thrombocytopenia (HIT) and Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Testing.
Lee CSM; Powell MC; Chen VM
Methods Mol Biol; 2023; 2663():441-461. PubMed ID: 37204729
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT).
Greinacher A; Schönborn L; Siegerist F; Steil L; Palankar R; Handtke S; Reder A; Thiele T; Aurich K; Methling K; Lalk M; Völker U; Endlich N
Semin Hematol; 2022 Apr; 59(2):97-107. PubMed ID: 35512907
[TBL] [Abstract][Full Text] [Related]
17. Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US.
Rodriguez EVC; Bouazza FZ; Dauby N; Mullier F; d'Otreppe S; Jissendi Tchofo P; Bartiaux M; Sirjacques C; Roman A; Hermans C; Cliquennois M
Infection; 2022 Apr; 50(2):531-536. PubMed ID: 34626338
[TBL] [Abstract][Full Text] [Related]
18. Investigation of anti-PF4 versus anti-PF4/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT.
Warkentin TE; Arnold DM; Sheppard JI; Moore JC; Kelton JG; Nazy I
J Thromb Haemost; 2023 Aug; 21(8):2268-2276. PubMed ID: 37182698
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia.
Liu Y; Shao Z; Wang H
Thromb Res; 2022 Jan; 209():75-79. PubMed ID: 34894531
[TBL] [Abstract][Full Text] [Related]
20. Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P's) for anti-PF4 diseases.
Gabarin N; Hack M; Revilla R; Arnold DM; Nazy I
Expert Rev Hematol; 2024; 17(1-3):39-45. PubMed ID: 38149432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
